A novel dynamic nomogram based on contrast-enhanced computed tomography radiomics for prediction of glypican-3-positive hepatocellular carcinoma
BackgroundThe 5-year overall survival of hepatocellular carcinoma (HCC) is still poor. Since glypican-3 (GPC3) is highly expressed in most HCC but not in healthy or non-malignant livers, it may become an ideal therapeutic target for HCC. Thus, this study aimed to construct a dynamic nomogram based o...
Gorde:
| Egile Nagusiak: | , , , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Frontiers Media S.A.
2025-10-01
|
| Saila: | Frontiers in Oncology |
| Gaiak: | |
| Sarrera elektronikoa: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1640697/full |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|